Hypertension (high blood pressure) decisions — 2025

The Board denied a compensable rating for the Veteran's hypertension as there was no evidence of diastolic pressure predominantly 100 or more, systolic pressure predominantly 160 or more, or a history of diastolic pressure predominantly 100 or more.

The Board granted a 10 percent initial rating for hypertension and denied an earlier effective date for service connection based on the Veteran's exposure to herbicide agents during his service in Vietnam.

The Board granted an earlier effective date of June 23, 2003 for the grant of service connection for hypertension and higher initial disability ratings for diabetic peripheral neuropathy in both upper extremities.

The appeal was dismissed due to the Veteran's explicit and unambiguous withdrawal of all claims except for his hypertension claim.

The Board granted an increased rating of 10 percent for the service-connected residual scar, status post coronary artery bypass graft and denied an earlier effective date prior to August 10, 2022, for service connection for ischemic heart disease associated with herbicide exposure. The claim for a compensable rating for hypertension was remanded.

The Board denied a compensable rating for hypertension as the evidence did not show diastolic pressure predominantly 100 or more, systolic pressure predominantly 160 or more, or a history of diastolic pressure predominantly 100 or more requiring continuous medication for control.

The Board denied service connection for DMII, diabetic retinopathy, bilateral hearing loss, and hypertension but granted an effective date of March 17, 2022, for the award of service connection for migraine headaches and special monthly compensation based on the need for aid and attendance.

The Board denied the Veteran's claims for an earlier effective date for TDIU, a compensable rating for hypertension, and an earlier effective date for DEA benefits.

The Board remands the appeal to obtain an additional medical opinion regarding whether the Veteran's diabetes mellitus, type II is related to in-service asbestos exposure.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board denied the veteran's claims for a higher rating for lumbosacral degenerative arthritis, a compensable rating for bilateral hearing loss, and service connection for hypertension.

The Board denied service connection for an acquired psychiatric disorder and hypertension, but granted service connection for lumbosacral strain with intervertebral disc disease (IVDS).

The Board remands the claims for service connection due to new and relevant evidence having been received since a previous denial.

The Board denied the claim for an earlier effective date before August 17, 2010, for a TDIU.

The Board granted a 10 percent disability rating for the service-connected hypertension, resolving reasonable doubt in favor of the Veteran.

The Board granted an initial increased rating of 10 percent for hypertension, as the Veteran's systolic pressure was predominantly 160 or more during the appeal period.

The Board remands the claims for service connection for ischemic heart disease and hypertension due to a need for further development regarding the Veteran's exposure to Agent Orange.

The Veteran is granted special monthly compensation based on the need for regular aid and attendance of another individual due to his service-connected disabilities.

The Board granted service connection for an acquired psychiatric disorder as it was caused by the Veteran's service-connected skin disabilities. The other issues were remanded for further development.

The Board remands the claims for service connection for obstructive sleep apnea, hypertension, diabetes mellitus type II, and peripheral neuropathy of the lower extremities to obtain additional medical opinions.